SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.

$9.28
As of 02/26/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
Israel

02/01/2018
22,972,948
30,919
$204,459,237
0.00%
SEC Edgar Online
20-F
M8694L103


Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-7.25
3.73
19.05
-51.44%
-273.91%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy